|
AU753268B2
(en)
*
|
1997-12-31 |
2002-10-10 |
Jun Sung Kim |
Heterocyclic topoisomerase poisons
|
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
|
JP2003501488A
(ja)
*
|
1999-06-11 |
2003-01-14 |
ネオルックス コーポレイション |
骨髄抑制のための高投与量放射性核種錯体
|
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
EP1390081A2
(en)
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutic and diagnostic compounds, compositions, and methods
|
|
JP4789414B2
(ja)
*
|
2001-11-14 |
2011-10-12 |
ラトガーズ，ザ ステイト ユニバーシティ |
可溶化トポイソメラーゼ毒性剤
|
|
WO2003041660A2
(en)
*
|
2001-11-14 |
2003-05-22 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
ES2311639T3
(es)
*
|
2001-11-14 |
2009-02-16 |
Rutgers, The State University |
Agentes citotoxicos.
|
|
ATE390923T1
(de)
*
|
2001-11-14 |
2008-04-15 |
Univ Rutgers |
Topoisomerase-giftmittel
|
|
WO2003051403A1
(en)
|
2001-12-13 |
2003-06-26 |
Dow Global Technologies Inc. |
Treatment of osteomyelitis with radiopharmaceuticals
|
|
WO2004014918A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted topoisomerase agents
|
|
US6992089B2
(en)
*
|
2002-08-09 |
2006-01-31 |
Rutgers, The University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
WO2004014862A1
(en)
*
|
2002-08-09 |
2004-02-19 |
Rutgers, The State University |
Nitro and amino substituted heterocycles as topoisomerase i targeting agents
|
|
AU2003290818A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Edmond J. Lavoie |
Topoisomerase-targeting agents
|
|
GB0619325D0
(en)
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
DK2403856T3
(da)
|
2009-03-06 |
2013-04-08 |
Univ Rutgers |
Methylendioxybenzo[i]phenanthridinderivater anvendt til behandling af cancer
|
|
WO2010127363A1
(en)
|
2009-05-01 |
2010-11-04 |
Rutgers, The State University Of New Jersey |
Toposiomerase inhibitors
|
|
ES2803556T3
(es)
*
|
2010-06-01 |
2021-01-27 |
Summit Oxford Ltd |
Compuestos para el tratamiento de enfermedades asociadas a clostridium difficile
|
|
US9920014B2
(en)
|
2013-09-19 |
2018-03-20 |
The Florida International University Board Of Trustees |
Selective inhibition of bacterial topoisomerase I
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017125944A1
(en)
*
|
2016-01-23 |
2017-07-27 |
Jawaharlal Nehru University (Jnu) |
Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase ia and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
|
|
JP2019515025A
(ja)
|
2016-04-04 |
2019-06-06 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
トポイソメラーゼ毒
|
|
WO2019004254A1
(ja)
|
2017-06-27 |
2019-01-03 |
株式会社Ｋｙｕｌｕｘ |
発光材料、化合物、遅延蛍光体および発光素子
|
|
JP7267563B2
(ja)
|
2017-06-27 |
2023-05-02 |
株式会社Kyulux |
発光材料、化合物、遅延蛍光体および発光素子
|